Search

Search Constraints

You searched for: Author/Creator Wolters, Pamela

Search Results

1. Neurocognitive functioning in symptomatic adults with sickle cell disease: A description and comparison with unaffected siblings. Issue 9 (20th October 2020)

2. NFM-07. SPRINT: PHASE II STUDY OF THE MEK 1/2 INHIBITOR SELUMETINIB (AZD6244, ARRY-142886) IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1 (NF1) AND INOPERABLE PLEXIFORM NEUROFIBROMAS (PN). Issue 2 (22nd June 2018)

3. Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas123. Issue 3 (7th September 2012)

4. QOL-55. HOME PHYSICAL ACTIVITY INTERVENTION TO IMPROVE COGNITIVE LATE EFFECTS IN CHILDREN TREATED WITH RADIATION FOR BRAIN TUMORS: DESCRIPTIVE FEASIBILITY DATA FROM A PILOT RANDOMIZED CONTROLLED TRIAL (RCT). Issue 2 (22nd June 2018)

5. QOL-55. HOME PHYSICAL ACTIVITY INTERVENTION TO IMPROVE COGNITIVE LATE EFFECTS IN CHILDREN TREATED WITH RADIATION FOR BRAIN TUMORS: DESCRIPTIVE FEASIBILITY DATA FROM A PILOT RANDOMIZED CONTROLLED TRIAL (RCT). Issue 2 (22nd June 2018)

6. Sirolimus for non‐progressive NF1‐associated plexiform neurofibromas: An NF clinical trials consortium phase II study. Issue 6 (25th November 2013)

7. Sirolimus for progressive neurofibromatosis type 1–associated plexiform neurofibromas: a Neurofibromatosis Clinical Trials Consortium phase II study. Issue 4 (14th October 2014)

8. Verbal learning and memory in youth with neurofibromatosis type 1 and plexiform neurofibromas: Relationships with disease severity. (May 2022)